Skip to main content
SpringerLink
Log in

Hemostatic complications in renal disorders of the young

  • Practical Pediatric Nephrology
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

This review focuses on the hemorrhagic and thrombotic complications sometimes associated with the most common renal disorders in children. A Medline search of the literature was conducted from 1966 to January 1995, using combinations of key words appropriate for each disorder. Additional references were located through the bibliographies of the publications and recent journals were searched independently. The most common renal disorders with hemostatic complications in children were: renal vein thrombosis (268 children in 80 publications), hemolytic uremic syndrome (473 children in 29 publications), nephrotic syndrome (4,158 children in 51 publications), renal transplantation (3,976 children in 14 publications), glomerulonephritis (20 publications). The age distribution, clinical presentation, etiology, diagnosis, treatment, and outcome of the affected children were analyzed for each disorder. Children with inherited pre-thrombotic disorders usually do not present during childhood unless there is a secondary risk factor. Similarly, most children with renal disease do not develop thromboembolic complications. Therefore, when a child with a renal disorder develops a thromboembolic event, evaluation for an inherited pre-thrombotic disorder should be seriously considered. Guidelines for the use of heparin and warfarin in these children (both therapeutically and prophylactically) are given. At this time, the risk/benefit of thrombolytic therapy in children is not known and a general recommendation for thrombolytic therapy cannot be made.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Schmidt B, Andrew M (1995) Neonatal thrombosis: report of a prospective Canadian and International registry. Pediatrics (in press)

  2. Harris JD, Ehrenfeld WK, Lee JC, Wylie EJ (1968) Experimental renal vein occlusion. Surg Gynecol Obstetr 126: 555

    Google Scholar 

  3. Crummy AB, Hipona FA (1965) The roentgen diagnosis of renal vein thrombosis; experimental aspects. Am J Roentgen 93: 898

    Google Scholar 

  4. Koehler PR, Bowles WT, McAlister WH (1966) Renal arteriography in experimental renal vein occlusion. Radiology86: 851

    Google Scholar 

  5. Osborne ED, Sutherland CG, Scholl AG, Rowntree LG, Landmark article Feb 10, 1923: Roentgenography of urinary tract during excretion of Sodium iodide. Jama 250 (20): 2818–2853, 1983

    Google Scholar 

  6. Rogers P, Silva M, Carter J, Wadsworth L (1989) Renal vein thrombosis and response to therapy in a newborn due to protein C deficiency. Eur J Pediatr 149: 124–125

    Google Scholar 

  7. Kaplan BS, Cleary TG, Obrig TG (1990) Recent advances in understanding the pathogenesis of the hemolytic uremic syndromes. Pediatr Nephrol 4: 276–283

    Google Scholar 

  8. Loirat C, Sonsino E, Hinglais N, Jais J, Landais P, Fermanian J (1988) Treatment of the childhood haemolytic uraemic syndrome with plasma. Pediatr Nephrol 2: 279–285

    Google Scholar 

  9. Rizzoni G, Claris-Appiani A, Edefonti A, Facchin P, Franchini F, Gusmano R, Imbasciati E, Pavanello L, Perfumo F, Remuzzi G (1988) Plasma infusion for hemolytic-uremic syndrome in children: results of a multi-center controlled trial. J Pediatr 112: 284–290

    Google Scholar 

  10. Vitacco M, Avalos J, Gianantonio C (1973) Heparin therapy in the hemolytic-uremic syndrome. J Pediatr 83: 271–275

    Google Scholar 

  11. Robson W, Leung AKC, Kaplan BS (1993) Hemolytic-uremic syndrome. Curr Opin Pediatr 23 (1): 16–33

    Google Scholar 

  12. Kar NCAJ van der, Hinsbergh VWM van, Brommer EJP, Monnens LAH (1994) The fibrinolytic system in the hemolytic uremic syndrome: in vivo and in vitro studies. Pediatr Res 36: 257–264

    Google Scholar 

  13. Monteagudo J, Pereira A, Reverter JC, Pijoan J, Tusell J, Ordinas A, Castille R (1991) Thrombin generation and fibrinolysis in the thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome. Thromb Haemost 55: 515–519

    Google Scholar 

  14. Suffredini AF, Harpel PC, Parillo JE (1989) Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. N Engl J Med 320: 1165–1172

    Google Scholar 

  15. Hinsbergh VWM van, Bauer KA, Kooistra T, Kluft C, Dooijewaard G, Sherman ML, Nieuwenhuizen W (1990) Progress of fibrinolysis during tumor necrosis factor infusions in humans. Concomitant increase in tissue-type plasminogen activator, plasminogen activator inhibitor type-1, and fibrin(ogen) degradation products. Blood 76: 2284–2289

    Google Scholar 

  16. Boyd B, LingwoodC (1989) Verocytotoxin receptor glycolipid in human renal tissue. Nephron 51: 207–210

    Google Scholar 

  17. Ogborn MR, Crocker JFS, Barnard DR (1990) Plasma therapy for severe hemolytic-uremic syndrome in children in Atlantic Canada. Can Med Assoc J 143: 1323–1326

    Google Scholar 

  18. Hoyer PF, Gonda S, Barthels M, Krohn HP, Brodehl J (1986) Thromboembolic complications in children with nephrotic syndrome. Acta Paediatr Scand 75: 804–810

    Google Scholar 

  19. Huttunen NP (1976) Congenital nephrotic syndrome of Finnish type. Arch Dis Child 51: 344–348

    Google Scholar 

  20. Mahan JD, Mauer SM, Sibley RK, Vernier RL (1984) Congenital nephrotic syndrome: evolution of medical management and results of renal transplantation. J Pediatr 105: 549–557

    Google Scholar 

  21. Mehls O, Andrassy K, Koderisch J, Herzog U, Ritz E (1987) Hemostasis and thromboembolism in children with nephrotic syndrome: differences from adults. J Pediatr 110: 862–867

    Google Scholar 

  22. Andrassy K, Ritz E, Bommer J (1980) Hypercoagulability in the nephrotic syndrome. Klin Wochenschr 58: 1029–1036

    Google Scholar 

  23. Kanfer A, Kleinknecht D, Broyer M, Josso F (1970) Coagulation studies in 45 cases of nephrotic syndrome without uremia. Thromb Diath Haemorrh 24: 562–571

    Google Scholar 

  24. Kauffman RH, Keltkamp JJ, Tilburg NH van, Es LA van (1978) Acquired antithrombin III deficiency and thrombosis in the nephrotic syndrome. Am J Med 65: 607–613

    Google Scholar 

  25. Kuhlmann U, Blattler W, Pouliadis G, Siegenthaler W (1979) Komplikationen des nephrotischen Syndroms unter besonderer Berücksichtigung thrombotischer Zwischenfälle. Schweiz. Med Wochenschr 109: 200–209

    Google Scholar 

  26. Schrader J, Kostering H, Zuchner C, Kaiser H, Kramer P, Scheler F (1981) Antithrombin III-Bestimmung im Schnelltest: Ein Vergleich mit Partigen-Platten und einem chromogenen Substrat. Lab Med 5: 211–218

    Google Scholar 

  27. Thaler E, Baler E, Kopsa H, Pinggera WF (1978) Acquired antithrombin III deficiency in patients with glomerular proteinuria. Haemostasis 7: 257–272

    Google Scholar 

  28. Cameron JS (1991) Coagulation and thromboembolic complications in the nephrotic syndrome (Review). Adv Nephrol Advances in Nephrology from the Necker Hospital 13: 75–114, 1984

    Google Scholar 

  29. Chugh K, Malik N, Uberoi H, Gupta V, Aggarwal M, Singhal P, Suri S, Jain S (1981) Renal vein thrombosis in nephrotic syndrome — a prospective study and review. Postgrad Med J 57: 566–570

    Google Scholar 

  30. Wei LQ, Rong ZK, Gui L, ShanRD (1991) CT diagnosis of renal vein thrombosis in nephrotic syndrome. J Comput Assist Tomogr 15: 454–457

    Google Scholar 

  31. Menzel D, Levi M, Dooijewaard G, Peters M, Cate J ten (1994) Impaired fibrinolysis in the hemolytic-uremic syndrome of childhood. Ann Hematol68: 43–48

    Google Scholar 

  32. Schieppati A, Dodesini P, Benigni A (1984) The metabolism of arachidonic acid by platelets in nephrotic syndrome. Kidney Int 25: 671–676

    Google Scholar 

  33. Stuart MJ, Spitzer R, Nelson DA, Sills RH (1980) Nephrotic syndrome: increased platelet prostaglandin endoperoxide formation, hyperaggregability, and reduced platelet life span. Reversal following remission. Pediatr Res 14: 1078–1081

    Google Scholar 

  34. Cameron J, Gill D, Turner D, Chantler C, Ogg C, Vosnides G, Williams D (1975) Combined immunosuppression and anticoagulation in rapidly progressive glomerulonephritis. Lancet II: 923–925

    Google Scholar 

  35. Haycock G (1988) The treatment of glomerulonephritis in children. Pediatr Nephrol 2: 247–255

    Google Scholar 

  36. Robson A, Cole B, Kienstra R, Kissane J, Alkjaersig N, Fletcher A (1977) Severe glomerulonephritis complicated by coagulopathy: treatment with anticoagulant and immunosuppressive drugs. J Pediatr 90: 881–892

    Google Scholar 

  37. Savage J, Postlethwaite R, Lendon M, Houston I, EvansD (1982) Combined immunosuppressive and anticoagulant treatment in children with glomerulonephritis and declining renal function. Int J Pediatr Nephrol 3: 167–174

    Google Scholar 

  38. Srivastrava R, Choudry V (1980) Rapidly progressive (crescentic) glomerulonephritis. Int J Pediatr Nephrol 1: 94–96

    Google Scholar 

  39. Leititis JU, Brandis M (1992) Critical care in uraemic children. Pediatr Nephrol 6: 88–95

    Google Scholar 

  40. Andrew M, Vegh P, Johnston M, Bowker J, Ofosu F, Mitchell L (1992) Maturation of the hemostatic system during childhood. Blood 80: 1998–2005

    Google Scholar 

  41. Andrew M, Castle V, Mitchell L, Paes B (1989) A modified bleeding time in the infant. Am J Hematol 30: 190–191

    Google Scholar 

  42. Bowker J, Andrew M, Paes B (1990) Assessing bleeding disorders in the newborn. Can J Diagn 149–164

  43. Feusner JH (1980) Normal and abnormal bleeding times in neonates and young children utilizing a fully standardized template technique. Am J Clin Pathol 74: 73–77

    Google Scholar 

  44. Fabris F, Cordiano I, Randi ML, Casonato A, Montini G (1991) Effect of human recombinant erythropoietin on bleeding time, platelet number and function in children with end-stage renal disease maintained by haemodialysis. Pediatr Nephrol 5: 225–228

    Google Scholar 

  45. Sloand EM, Sloand JA, Prodouz K, Klein HG, Harvath L, Fricke W (1991) Reduction of platelet glycoprotein Ib in uraemia. Br J Haematol 77: 375–381

    Google Scholar 

  46. Eberst M, Berkowitz L (1994) Hemostasis in renal disease: pathophysiology and management. Am J Med 96: 168–178

    Google Scholar 

  47. Gralnick H, McKeown L, Williams S, Shafer B, Pierce L (1988) Plasma and platelet von-Willebrand factor in uremia. Am J Med 85: 806–810

    Google Scholar 

  48. Kazatchkine M, Sultan Y, Caen J, Bariety J (1976) Bleeding in renal failure: a possible cause. BMJ 2: 612–615

    Google Scholar 

  49. Remuzzi G (1990) Bleeding disorders in uremia: pathophysiology and treatment. Adv Nephrol 18: 171–186

    Google Scholar 

  50. Gralnick HR, McKeown LP, Williams SB, Shafer BC (1988) Plasma and platelet von Willebrand factor defects in uremia. Am J Med 85: 806–810

    Google Scholar 

  51. Janson PA, Jubelirer SJ, Weinstein MJ, Deykin D (1980) Treatment of the bleeding tendency in uremia with cryoprecipitate. N Engl J Med 303: 1318–1322

    Google Scholar 

  52. Mannucci PM, Remuzzi G, Pusineri F, Lombardi R, Valsecchi C, Mecca G, Zimmerman TS (1983) Deamino-8-d-arginine vasopressin shortens the bleeding time in uremia. N Engl J Med 308: 8–12

    Google Scholar 

  53. Vigano G, Gaspari F, Locatelli M, Pusineri F, Bonati M, Remuzzi G (1988) Dose-effect and pharmacokinetics of estrogens given to correct bleeding time in uremia. Kidney Int 34: 853–858

    Google Scholar 

  54. Vigano G, Mannucci PM, Lattuada A, Harris A, Remuzzi G (1989) Subcutaneous desmopressin (DDAVP) shortens the bleeding time in uremia. Am J Hematol 31: 32–35

    Google Scholar 

  55. Remuzzi G, Pusineri F (1988) Coagulation defects in uremia. Kidney Int 33 [Suppl 24]: S13-S17

    Google Scholar 

  56. McFarland JG, Aster RH, Bussel JB, Gianopoulos JG, Derbes RS, Newman PJ (1991) Prenatal diagnosis of neonatal alloimmune thrombocytopenia using allele-specific oligonucleotide probes. Blood 78: 2276–2282

    Google Scholar 

  57. Eknoyan G, Wacksman S, Glueck H, Will J (1969) Platelet function in renal failure. N Engl J Med 280: 677–681

    Google Scholar 

  58. Larsson S, Hedner U, Nilsson I (1971) On coagulation and fibrinolysis in uraemic patients on maintenance haemodialysis. Acta Med Scand 189: 443–451

    Google Scholar 

  59. Delorme M, Saeed N, Sevcik A, Mitchell L, Berry L, Johnston M, Andrew M (1993) Plasma dermatan sulfate proteoglycan in a patient on chronic hemodialysis. Blood 82: 3380–3385

    Google Scholar 

  60. Fernandez F, Goudable C, Sie P, Ton-That H, Durand D, Suc JM, Boneu B. Low haematocrit and prolonged bleeding time in uraemic patients: effect of red cell transfusions. Br J Haematol 59 (1) 139–148, 1985

    Google Scholar 

  61. Livio M, Marchesi D, Remuzzi G, Gotti E, Mecca G, de Gaetano G (1982) Uraemic bleeding: role of anaemia and beneficial effect of red cell transfusions. Lancet 2 (2306): 1013–1015

    Google Scholar 

  62. Cases A, Escolar G, Reverter JC, Ordinas A, Lopez-Pedret J, Revert L, Castillo R (1992) Recombinant human erythropoietin treatment improves platelet function in uremic patients. Kidney Int 42: 668–672

    Google Scholar 

  63. Nenci G, Berretine M, Agnelli G, Parice P, Bouncristiani W, Ballatori E (1979) Effect of peritoneal dialysis, hemodialysis, and kidney transplantation on blood platelet function. Nephron 23: 287–292

    Google Scholar 

  64. Pales JL, Lopez A, Asensio A, Merola E, Company X, Deulofeu R, Garcia M, Balague A (1987) Inhibitory effect of peak 2–4 of uremic middle molecules on platelet aggregation. Eur J Haematol 39: 197–202

    Google Scholar 

  65. Remuzzi G, Livio M, MarchiaroG, Mecca G, DeGaetano G (1978) Bleeding in renal failure: altered platelet function in chronic uremia only partially corrected by hemodialysis. Nephron 22: 347–353

    Google Scholar 

  66. Abman SH (1994) Pathogenesis and treatment of neonatal and postnatal pulmonary hypertension (Review) Curr Opinion Pediatr 6 (3): 239–247

    Google Scholar 

  67. Finer NN, Etches PC, Kamstra B, Tierney AJ, Peliowski A, Ryan CA (1994) Inhaled nitric oxide in infants referred for extracorporeal membrane oxygenation: dose response. J Pediatr 124: 302–308

    Google Scholar 

  68. Kinsella JP, Neish SR, Ivy DD, Shaffer E, Abman SH (1993) Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide. J Pediatr 123: 103–108

    Google Scholar 

  69. Remuzzi G, Perico N, Zoja C, Macconi D, Vigano G (1990) Role of endothelium-derived nitric oxide in the bleeding tendency of uremia. J Clin Invest 86: 1768–1771

    Google Scholar 

  70. Geary DF, Gajaria M, Fryer-Keene S, Willumsen J (1991) Low-dose and heparin-free hemodialysis in children. Pediatr Nephrol 5: 220–224

    Google Scholar 

  71. Borm J, Krediet R, Sturk A, Cate J ten (1986) Heparin versus low molecular weight heparin K2165 in chronic hemodialysis patients: a randomized cross-over study. Haemostasis 16: 59–68

    Google Scholar 

  72. Lane D, Flynn A, Ireland H, Anastassiades E, Curtis J (1986) On the evaluation of heparin and low-molecular-weight heparin in hemodialysis for chronic renal failure. Haemostasis 16 [Suppl 2]: 38–47 (Abstract)

    Google Scholar 

  73. Wessler S, Reimer S, Sheps M (1959) Biological assay of a thrombosis inducing activity in human serum. J Appl Physiol 14: 943–946

    Google Scholar 

  74. Abejo RC, John EG, Spigos DG (1985) Low-dose streptokinase-induced clot lysis of an occluded arteriovenous fistula. J Pediatr 106: 321–323

    Google Scholar 

  75. Rodkin RS, Bookstein JJ, Heeney DJ, Davis GB (1983) Streptokinase and transluminal angioplasty in the treatment of acutely thrombosed hemodialysis access fistulas. Radiology 149: 425–428

    Google Scholar 

  76. Young AT, Hunter DW, Castaneda-Zuniga WR, So SKS, Mercado S, Cardella JF, Amplaz K (1985) Thrombosed synthetic hemodialysis access fistulas: failure of fibrinolytic therapy. Radiology 154: 639–642

    Google Scholar 

  77. Churchill BM, Sheldon CA, McLorie GA, Arbus GS (1988) Factors influencing patient and graft survival in 300 cadaveric pediatric renal transplants. J Urol 140: 1129–1133

    Google Scholar 

  78. Broyer M (1989) Kidney transplantation in children-data from the EDTA registry. Transplant Proc 21: 1985–1988

    Google Scholar 

  79. Broyer M, Mitsioni A, Gagnadoux MF, Fischer AM, Beurton D, Niaudet P, Habib R (1993) Early failures of kidney transplantation: a study of 70 cases from 801 consecutive grafts performed in children and adolescents. Adv Nephrol 22: 169

    Google Scholar 

  80. Harmon WE, Stablein D, Alexander SR, Tejani A (1991) Graft thrombosis in pediatric renal transplant recipients. Transplantation 51: 406–412

    Google Scholar 

  81. Kalicinski P, Kaminski A, Prokural A, Grenda R, Smirska E, Chrupek M, Szymczak M, Drewniak T, Ishmail H (1994) Surgical complications after kidney transplantation in children. Transplant Proc 26: 42–43

    Google Scholar 

  82. Sheldon CA, Churchill BM, McLorie GA, Arbus GS (1992) Evaluation of factors contributing to mortality in pediatric renal transplant recipients. J Pediatr Surg 27: 629–633

    Google Scholar 

  83. Valdes R, Munoz R, Bracho E, Gordillo G, Velazquez L, Nieto J (1994) Surgical complications of renal transplantation in malnourished children. Transplant Proc 26: 50–51

    Google Scholar 

  84. McEnery PT, Stablein DM, Arbus G, Tejani A (1992) Renal transplantation in children. A report of the North American Pediatric Renal Transplant Cooperative Study. N Engl J Med 326: 1727–1732

    Google Scholar 

  85. Andrew M, Berube C, Adams M, Vegh P (1995) The relationship between non-specific inhibitors in children with systemic lupus erythematosus and thromboembolic complications: a cross-sectional study. Lupus 3 (4): 360 Abstr 190, August 1994

    Google Scholar 

  86. Montes de Oca MA, Babron MC, Bletry O, Broyer M, Courtecuisse V, Fontaine JL, Loirat C, Mery JP, Reinert P, Wechsler B, Levy M (1991) Thrombosis in systemic lupus erythematosus: a French collaborative study. Arch Dis Child 66: 713–717

    Google Scholar 

  87. Lam AH, Shulman LA (1985) Ultrasound in congenital haemorrhage secondary to isoimmune thrombocytopenia. Pediatr Radiol 15: 8–11

    Google Scholar 

  88. Nuss R, Hays T, Manco-Johnson M (1994) Efficacy and safety of heparin anticoagulation for neonatal renal vein thrombosis. Am J Pediatr Hematol Oncol 16: 127–131

    Google Scholar 

  89. Van Damme-Lombaerts R, Proesmans W, Van Damme B, Eeckels R, Binda Ri Mucka P, Mercieca V, Vletinck R, Vermylen J (1988) Heparin plus dipyridamole in childhood hemolytic-uremic syndrome: a prospective, randomized study. J Pediatr 113: 913–918

    Google Scholar 

  90. Zobel G, Trop M, Muntean W, Ring E, Gleispach H (1988) Anticoagulation for continuous arteriovenous hemofiltration in children. Blood Purif 6: 90–95

    Google Scholar 

  91. Casu B, Oreste P, Torri G (1981) The structure of heparin oligosaccharide fragments with high anti-(factor Xa) activity containing the minimal antithrombin III-binding sequence. Biochem J 197: 599–609

    Google Scholar 

  92. Choay J, Lormeau JC, Petitou M, Sinay P, Fareed J (1981) Structural studies on a biologically active hexasaccharide obtained from heparin. Ann NY Acad Sci 370: 644–649

    Google Scholar 

  93. Hirsh J (1991) Heparin. N Engl J Med 324: 1565–1574

    Google Scholar 

  94. Levine MN, Hirsh J (1986) Hemorrhagic complications of anticoagulant therapy. Semin Thromb Haemost 12: 39–57

    Google Scholar 

  95. Nieuwenhuis HK, Albada J, Banga JD, Sixma JJ (1991) Identification of risk factors for bleeding during treatment of acute venous thromboembolism with heparin or low molecular weight heparin. Blood 78: 2337–2343

    Google Scholar 

  96. Shojania A, Tetreault J, Turnbull G (1988) The variations between heparin sensitivity of different lots of activated partial thromboplastin time reagent produced by the same manufacturer. Am J Clin Pathol 89: 19–23

    Google Scholar 

  97. Refn I, Vestergaard L (1954) The titration of heparin with protamine. Scand J Clin Lab Invest 6: 284–287

    Google Scholar 

  98. Teien AN, Lie M (1977) Evaluation of amidolytic heparin assay method. Increased sensitivity by adding purified antithrombin III. Thromb Res 10: 399–410

    Google Scholar 

  99. Chiu H, Hirsh J, Yung W, Regoeczi E, Gent M (1977) Relationship between the anticoagulant and antithrombotic effects of heparin in experimental venous thrombosis. Blood 49: 171–184

    Google Scholar 

  100. Levine M, Hirsh J, Gent M, Turpie A, Cruickshank M, Anderson D, Johnston M (1995) A randomized trial comparing the activated thromboplastin time with the heparin assay to monitor heparin therapy in patients with acute venous thromboembolism requiring large daily doses of heparin. Arch Intern Med (in press)

  101. Gillies H, Rogers HJ, Johnston J, Harper PG, Rudge CJ (1985) Is repeated flushing of Hickman catheters necessary? BMJ 290: 1708

    Google Scholar 

  102. Lombardi TP, Gundersen B, Zammett LO, Walters JK, Morris B (1988) Efficacy of 09% sodium chloride injection with or without heparin sodium for maintaining patency of intravenous catheters in children. Clin Pharm 7: 832–836

    Google Scholar 

  103. Smith SM, Dawson SM, Hennessey R, Andrew M (1991) Maintenance of the patency of indwelling central venous catheters: is heparin necessary. Am J Pediatr Hematol Oncol 13: 141–143

    Google Scholar 

  104. Bern MM, Lokich JJ, Wallach SR, Bothe AJ, Benotti PN, Arkin CF, Greco FA, Huberman M, MooreC (1990) Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial. Ann Intern Med 112: 423–428

    Google Scholar 

  105. Andrew M Marzinotto V Blanchette V Ginsberg J Burrows P Benson L Williams W David M Poon A Sparling C Heparin therapy in pediatric patients: A prospective cohort study. Pediatr Res 35: 78–83

  106. Cruickshank M, Levine M, Hirsh J, Roberts R, Siguenza M (1991) A standard heparin nomogram for the management of heparin therapy. Arch Intern Med 151: 333–337

    Google Scholar 

  107. Andrew M, Ofosu F, Schmidt B, Brooker L, Hirsh J, Buchanan M (1988) Heparin clearance and ex vivo recovery in newborn piglets and adult pigs. Thromb Res 52: 517–527

    Google Scholar 

  108. McDonald MM, JacobsonLJ, Hay WW, Hathaway WE (1981) Heparin clearance in the newborn. Pediatr Res 15: 1015–1018

    Google Scholar 

  109. Turner Gomes S, Nitschmann E, Benson L, Burrows P, Andrew M (1993) Heparin is cleared faster in children with congenital heart disease than adults. J Am Coll Cardiol 21: 59a (Abstract)

    Google Scholar 

  110. Basu D, Gallus A, Hirsh J, Cade J (1972) A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time. N Engl J Med 287: 324–327

    Google Scholar 

  111. Hull R, Raskob G, Hirsh J, et al. (1986) Continuous intravenous heparin compared to intermittent subcutaneous heparin in the initial treatment of proximal vein thrombosis. N Engl J Med 315: 1109–1114

    Google Scholar 

  112. Kaplan K, Davison R, Parker M, Mayberry B, Feiereisel P, Salinger M (1987) Role of heparin after intravenous thrombolytic therapy for acute myocardial infarction. Am J Cardiol 59: 241–244

    Google Scholar 

  113. Turpie A, RobinsonJ, Doyle D (1989) Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction. N Engl J Med 320: 352–357

    Google Scholar 

  114. Hirsh J (1991) Oral anticoagulant drugs. Review article. N Engl J Med 324: 1865–1875

    Google Scholar 

  115. Quick AJ, Grossman AM (1939) Prothrombin concentration in newborns. Proc Soc Exp Biol Med 41: 227

    Google Scholar 

  116. International Committee for Standardization in Haematology; International Committee on Thrombosis and Haemostasis (1985) ICSH/ICTH Recommendations for reporting prothrombin time in oral anticoagulant control. Thromb Haemost 53: 155–156

    Google Scholar 

  117. Loeliger E, Besselaar A van den, LewisS (1985) Reliability and clinical impact of the normalization of the prothrombin times in oral anticoagulant control. Thromb Haemost 53 (1): 148–154

    Google Scholar 

  118. Poller L (1987) Laboratory control of oral anticoagulants. BMJ 294: 1184

    Google Scholar 

  119. Poller L (1987) Progress in standardization anticoagulation control. Hematol Rev 1: 225–241

    Google Scholar 

  120. Roy A, Jaffe N, Djerassi I (1973) Prophylactic platelet transfusions in children with acute leukemia: a dose response study. Transfusion 13: 283

    Google Scholar 

  121. Hirsh J, Poller L, Deykin D, Levine M, Dalen JE (1989) Optimal therapeutic range for oral anticoagulants. Chest 95: 5S-11S

    Google Scholar 

  122. Kumar S, Haigh J, Rhodes L, Peaker S, Davies J, Roberts B, Feely M (1989) Poor compliance is a major factor in unstable outpatient control of anticoagulant therapy. Thromb Haemost 62: 729–732

    Google Scholar 

  123. Stewart S, Cianciotta D, Alexson C, Manning J (1987) The long-term risk of warfarin sodium therapy and the incidence of thromboembolism in children after prosthetic cardiac valves. J Thorac Cardiovasc Surg 93: 551–554

    Google Scholar 

  124. Harada Y, Imai Y, Kurosawa H, et al (1990) Ten-year follow-up after valve replacement with the St Jude Medical prosthesis in children. J Thorac Cardiovasc Surg 100: 175–180

    Google Scholar 

  125. McGrath L, Gonzalez-Lavin L, Edlredge W, Colombi M, Restrepo D (1987) Thromboembolic and other events following valve replacement in a pediatric population treated with antiplatelet agents. Ann Thorac Surg 43: 285–287

    Google Scholar 

  126. Spevak P, Freed M, Castaneda A, et al (1986) Valve replacement in children less than 5 years of age. Am J Cardiol 8: 901–908

    Google Scholar 

  127. Woods A, Vargas J, Berri G, Kreutzer G, Meschengieser S, Lazzari MA (1986) Antithrombotic therapy in children and adolescents. Thromb Res 42: 289–301

    Google Scholar 

  128. Andrew M, Marzinotto V, Brooker L, Adams M, Ginsberg J, Freedom R, Williams W (1994) Oral anticoagulant therapy in pediatric patients: a prospective study. Thromb Haemost 71: 265–269

    Google Scholar 

  129. Bradley LM, Midgley FM, Watson DC, et al (1985) Anticoagulation therapy in children with mechanical prosthetic cardiac valves. Am J Cardiol 56: 533–535

    Google Scholar 

  130. Carpentieri U, Nghiem QX, Harris LC (1976) Clinical experience with an oral anticoagulant in children. Arch Dis Child 51: 445–448

    Google Scholar 

  131. Doyle JJ, Koren G, Chen MY, Blanchette VS (1988) Anticoagulation with sodium warfarin in children: effect of a loading regimen. J Pediatr 113: 1095–1097

    Google Scholar 

  132. Kellam B, Fraze D, Kanarek K (1987) Clot lysis for thrombosed central venous catheters in pediatric patients. J Perinatol 7: 242–244

    Google Scholar 

  133. Mirro JJ, Rao BN, Stokes DC, Austin BA, Kumar M, Dabe GV, Colten M, Balas L, Rafferty M, Hancock M, Fairclough D (1989) A prospective study of Hickman/Broviac catheters and implantable ports in pediatric oncology patients. J Clin Oncol 7: 214–222

    Google Scholar 

  134. Morris J, Occhionero M, Gauderer M, et al (1990) Totally implantable vascular access devices in cystic fibrosis: a four-year experience with fifty-eight patients. J Pediatr 117: 82–85

    Google Scholar 

  135. Winthrop AL, Wesson DE (1984) Urokinase in the treatment of occluded central venous catheters in children. J Pediatr Surg 19: 536–538

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Henderson General Division, Hamilton Civic Hospitals Research Center, 711 Concession Street, 60 Wing, 2nd Floor, L8V 1C3, Hamilton, Ontario, Canada

    Maureen Andrew & Lu Ann Brooker

Authors
  1. Maureen Andrew
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lu Ann Brooker
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Andrew, M., Brooker, L.A. Hemostatic complications in renal disorders of the young. Pediatr Nephrol 10, 88–99 (1996). https://doi.org/10.1007/BF00863459

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00863459

Key words

Search

Navigation